Pfizer Inc said today that final results from the late-stage trial of its Covid-19 vaccine show it was 95pc effective, adding it had the required two-months of safety data and would apply for emergency US authorisation within days.
Read more here:: Pfizer say vaccine is 95pc effective after ending Covid trial and is now seeking emergency-use authorisation
